 REHOVOT, Israel , April 2, 2021 PRNewswire -- Evogene Ltd. NASDAQ: EVGN TASE: EVGN, a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission the SEC. 